127 related articles for article (PubMed ID: 33399022)
1. Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance: potential implications for surveillance goal.
Song JH; Goh MJ; Park Y; Oh JH; Kang W; Sinn DH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Scand J Gastroenterol; 2021 Mar; 56(3):274-280. PubMed ID: 33399022
[TBL] [Abstract][Full Text] [Related]
2. Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation.
Liu W; Zheng Y; Zou R; Shen J; He W; Yang Z; Zhang Y; Li B; Yuan Y
BMC Cancer; 2018 Nov; 18(1):1186. PubMed ID: 30497418
[TBL] [Abstract][Full Text] [Related]
3. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
[TBL] [Abstract][Full Text] [Related]
4. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
[TBL] [Abstract][Full Text] [Related]
5. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
[TBL] [Abstract][Full Text] [Related]
7. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma.
Ma XL; Zhou JY; Gao XH; Tian L; Wu J; Zhang CY; Zhou Y; Dai Q; Wang BL; Pan BS; Yang XR; Guo W
Clin Chim Acta; 2016 Nov; 462():15-22. PubMed ID: 27520748
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with late hepatocellular carcinoma detection in patients undergoing regular surveillance.
Jang S; Jin YJ; Lee JW; Kwon D; Yu JH
Medicine (Baltimore); 2023 Aug; 102(32):e34637. PubMed ID: 37565915
[TBL] [Abstract][Full Text] [Related]
9. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Costentin CE; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Letouzé E; Imbeaud S; Zucman-Rossi J; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2018 Aug; 155(2):431-442.e10. PubMed ID: 29729258
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.
Kikuchi L; Menezes M; Chagas AL; Tani CM; Alencar RS; Diniz MA; Alves VA; D'Albuquerque LA; Carrilho FJ
World J Gastroenterol; 2014 Feb; 20(6):1585-93. PubMed ID: 24587635
[TBL] [Abstract][Full Text] [Related]
11. [Long term (5 years) outcome of radiofrequency ablation for hepatocellular carcinoma in 256 cases].
Chen MH; Yan K; Yang W; Gao W; Dai Y; Huo L; Zhang H; Huang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):671-2. PubMed ID: 16378128
[TBL] [Abstract][Full Text] [Related]
12. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
Kuo MJ; Mo LR; Chen CL
BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
[TBL] [Abstract][Full Text] [Related]
14. Single-nodule hepatitis B virus-associated hepatocellular carcinoma smaller than 3 cm: two phenotypes defined by cluster analysis and their association with the outcome of ablation as the first-line therapy.
Chen S; Wu Y; Qi H; Shen L; Ma W; Cao F; Diao Y; Wang T; Ou S; Fan W
Int J Hyperthermia; 2021; 38(1):120-129. PubMed ID: 33541160
[TBL] [Abstract][Full Text] [Related]
15. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
[TBL] [Abstract][Full Text] [Related]
16. Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis.
Del Poggio P; Olmi S; Ciccarese F; Di Marco M; Rapaccini GL; Benvegnù L; Borzio F; Farinati F; Zoli M; Giannini EG; Caturelli E; Chiaramonte M; Trevisani F;
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1927-33.e2. PubMed ID: 24582947
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of prognosis and recurrence of hepatocellular carcinoma treated from 1988 to 2002 at Department of Medicine III, Kyushu University Hospital].
Arimura E; Nakamuta M; Kotoh K; Morizono S; Fukutomi M; Ohta S; Enjoji M; Sakai H; Nawata H
Fukuoka Igaku Zasshi; 2004 Aug; 95(8):195-200. PubMed ID: 15552961
[TBL] [Abstract][Full Text] [Related]
18. Natural history of hepatocellular carcinoma.
Colombo M
Ann Ital Chir; 2008; 79(2):91-7. PubMed ID: 18727270
[TBL] [Abstract][Full Text] [Related]
19. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
[TBL] [Abstract][Full Text] [Related]
20. Outcome of Hepatocellular Carcinoma Detected During Surveillance: Comparing USA and Japan.
Toyoda H; Hiraoka A; Olivares J; Al-Jarrah T; Devlin P; Kaneoka Y; Maeda A; Yopp AC; Parikh ND; Singal AG
Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2379-2388.e6. PubMed ID: 33295281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
